comparemela.com

Latest Breaking News On - Glenns tillotson - Page 1 : comparemela.com

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

Digestive Disease Week roundup: Colorectal cancer data dominated; what else did you miss?

Digestive Disease Week 2023 in Chicago may have ended in early May, but Healio coverage has continued all month long. Wondering what you missed and what is coming next? Healio recaps the biggest meeting news making waves in the specialty. Healio covered a variety of presentations from this year’s DDW annual meeting, with a significant focus on the latest data on colorectal cancer, including

Glenn S. Tillotson, PhD: Treating Immunocompromised Patients With RBX2660

RBX2660 showed similar efficacy and safety in treating patients with and without immunocompromised conditions.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.